Hachamovitch R, Berman D S, Kiat H, Cohen I, Cabico J A, Friedman J, Diamond G A
Department of Imaging, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Circulation. 1996 Mar 1;93(5):905-14. doi: 10.1161/01.cir.93.5.905.
We evaluated the incremental prognostic value, the role in risk stratification, and the impact on patient management of myocardial perfusion single-photon emission computed tomography (SPECT) in a population of patients without prior myocardial infarction, catheterization, or revascularization.
We examined 2200 consecutive patients who at the time of their dual-isotope SPECT had not undergone catheterization, coronary artery bypass surgery, or percutaneous transluminal coronary angioplasty and had no known history of previous myocardial infarction. Follow-up was performed at a mean of 566 +/- 142 days (97% complete) for hard events (cardiac death and myocardial infarction) and for referral to cardiac catheterization or revascularization within 60 days after nuclear testing. Examination of clinical, exercise, and nuclear models by use of pre-exercise tolerance test (ETT), post-ETT, and nuclear information using a stepwise Cox proportional hazards model and receiver-operating characteristic curve analysis revealed that nuclear testing added incremental prognostic value after inclusion of the most predictive clinical and exercise variables (global chi2 = 12 for clinical variables; 31 for clinical + exercise variables; 169 for nuclear variables; gain in chi2, P < .0001 for all; receiver-operating characteristic areas: 0.66 +/- 0.04 for clinical, 0.73 +/- 0.04 for clinical + exercise variables, 0.87 +/- 0.03 for nuclear variables, P = .03 for gain in area with exercise variables; P < .001 for increase with nuclear variables). Multiple logistic regression analysis revealed that scan information contributed 95% of the information regarding referral to catheterization with further additional information provided by presenting symptoms and exercise-induced ischemia. Referral rates to early catheterization and revascularization paralleled the hard event rates in all scan categories - very low referral rates in patients with normal scans and significant increases in referral rates as a function of worsening scan results. Even after stratification by clinical and exercise variables such as the Duke treadmill score, pre- and post-ETT likelihood of coronary artery disease, presenting symptoms, sex, and age, the nuclear scan results further risk-stratified the patient subgroups, thus demonstrating clinical incremental value.
In a patient population with no evidence of previous coronary artery disease at overall low risk (1.8% hard event rate), myocardial perfusion SPECT adds incremental prognostic information and risk-stratifies patients even after clinical and exercise information is known. It appears that referring physicians use this test in an appropriate manner in selecting patients to be referred to catheterization or revascularization.
我们评估了心肌灌注单光子发射计算机断层扫描(SPECT)在无既往心肌梗死、导管插入术或血运重建的患者群体中的增量预后价值、在风险分层中的作用以及对患者管理的影响。
我们检查了2200例连续患者,这些患者在进行双同位素SPECT检查时未接受过导管插入术、冠状动脉搭桥手术或经皮冠状动脉腔内血管成形术,且无既往心肌梗死病史。对严重事件(心源性死亡和心肌梗死)以及核素检查后60天内转诊至心脏导管插入术或血运重建的情况进行了平均566±142天(97%完整)的随访。通过使用运动前耐受试验(ETT)、ETT后以及核素信息,利用逐步Cox比例风险模型和受试者操作特征曲线分析对临床、运动和核素模型进行检查,结果显示,在纳入最具预测性的临床和运动变量后,核素检查增加了增量预后价值(临床变量的全局卡方值 = 12;临床 + 运动变量为31;核素变量为169;卡方值增加,所有P <.0001;受试者操作特征面积:临床为0.66±0.04,临床 + 运动变量为0.73±0.04,核素变量为0.87±0.03,运动变量面积增加的P = 0.03;核素变量增加的P <.001)。多元逻辑回归分析显示,扫描信息提供了关于转诊至导管插入术的95%的信息,而症状和运动诱发的缺血提供了进一步的额外信息。在所有扫描类别中,早期导管插入术和血运重建的转诊率与严重事件发生率平行——扫描正常的患者转诊率非常低,且转诊率随着扫描结果恶化而显著增加。即使根据临床和运动变量进行分层,如杜克运动平板评分、ETT前后冠状动脉疾病的可能性、症状、性别和年龄,核素扫描结果仍进一步对患者亚组进行了风险分层,从而证明了其临床增量价值。
在总体低风险(严重事件发生率为1.8%)且无既往冠状动脉疾病证据的患者群体中,心肌灌注SPECT即使在已知临床和运动信息后仍能增加增量预后信息并对患者进行风险分层。看来转诊医生在选择转诊至导管插入术或血运重建的患者时以适当方式使用了该检查。